NKX2-1 and neoplasm: Previous studies mainly reported favorable prognosis with NKX2-1 expression in mixed onco-driver, tumor stages and pathological backgrounds44,45, while our study demonstrated the predictive value of NKX2-1 copy number gain to favor adjuvant TKI treatment in a more defined population.